Evidence map›Paper›PMID 23271955›Full record

ArticlePLoS biology2012

Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase.

Mioara Larion, Roberto Kopke Salinas, Lei Bruschweiler-Li, Brian G Miller, Rafael Brüschweiler

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The disordered C-terminal tail of fungal LPMOs from phytopathogens mediates protein dimerization and impacts plant penetration.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular and cellular regulation of human glucokinase.Archives of biochemistry and biophysics · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Order, Disorder, and Everything in Between.Molecules (Basel, Switzerland) · 2016
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mioara LarionDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida, United States of America.
Roberto Kopke Salinas
Lei Bruschweiler-Li
Brian G Miller
Rafael Brüschweiler
Florida State University · USNational High Magnetic Field Laboratory · USUniversidade de São Paulo · BR

Funding

Human GlucokinaseR01DK081358 · NIDDK · FLORIDA STATE UNIVERSITY · PI MILLER, BRIAN GENE · 2009 to 2013
$1.4M
NIDDK NIH HHS 1R01DK081358NIDDK NIH HHS R01 DK081358
6 · The paper itself

Abstract

Glucokinase (GCK) catalyzes the rate-limiting step of glucose catabolism in the pancreas, where it functions as the body's principal glucose sensor. GCK dysfunction leads to several potentially fatal diseases including maturity-onset diabetes of the young type II (MODY-II) and persistent hypoglycemic hyperinsulinemia of infancy (PHHI). GCK maintains glucose homeostasis by displaying a sigmoidal kinetic response to increasing blood glucose levels. This positive cooperativity is unique because the enzyme functions exclusively as a monomer and possesses only a single glucose binding site. Despite nearly a half century of research, the mechanistic basis for GCK's homotropic allostery remains unresolved. Here we explain GCK cooperativity in terms of large-scale, glucose-mediated disorder-order transitions using 17 isotopically labeled isoleucine methyl groups and three tryptophan side chains as sensitive nuclear magnetic resonance (NMR) probes. We find that the small domain of unliganded GCK is intrinsically disordered and samples a broad conformational ensemble. We also demonstrate that small-molecule diabetes therapeutic agents and hyperinsulinemia-associated GCK mutations share a strikingly similar activation mechanism, characterized by a population shift toward a more narrow, well-ordered ensemble resembling the glucose-bound conformation. Our results support a model in which GCK generates its cooperative kinetic response at low glucose concentrations by using a millisecond disorder-order cycle of the small domain as a "time-delay loop," which is bypassed at high glucose concentrations, providing a unique mechanism to allosterically regulate the activity of human GCK under physiological conditions.

Indexed as

Allosteric RegulationAmino Acid SubstitutionCatalytic DomainCongenital HyperinsulinismEnzyme ActivationEnzyme StabilityGlucokinaseGlucoseHumansIsoleucineKineticsMagnetic Resonance SpectroscopyModels, BiologicalModels, MolecularProtein Structure, SecondaryProtein Structure, TertiaryGlucokinaseGlucoseIsoleucine

Identifiers

PMID23271955
PMCPMC3525530
OpenAlexW1981086730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.